LPL Financial
RGNX icon

LPL Financial’s Regenxbio RGNX Stock Holding History

LPL Financial’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-32,705
Closed -$471K – 6131
2025
Q4 		$471K Sell
32,705
-2,111
-6% -$26.3K ﹤0.01% 4767
2025
Q3 		$336K Sell
34,816
-3,222
-8% -$28.5K ﹤0.01% 4964
2025
Q2 		$312K Buy
38,038
+16,510
+77% +$138K ﹤0.01% 4740
2025
Q1 		$154K Buy
+21,528
New +$160K ﹤0.01% 4935
2020
Q1 		– Sell
-7,181
Closed -$294K – 3387
2019
Q4 		$294K Buy
+7,181
New +$284K ﹤0.01% 2785
2019
Q3 		– Sell
-4,123
Closed -$212K – 3370
2019
Q2 		$212K Sell
4,123
-449
-10% -$22.4K ﹤0.01% 2982
2019
Q1 		$262K Buy
+4,572
New +$226K ﹤0.01% 2748

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

LPL Financial's RGNX Position: Q1 2026 in Review

LPL Financial sold out of Regenxbio (RGNX) in Q1 2026, closing a stake of 32,705 shares — an estimated $471K sold.

LPL Financial first reported a position in RGNX in Q1 2019 and held it in 7 quarters. The position peaked at $471K in Q4 2025. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.

  • LPL Financial reported no remaining Regenxbio position as of Q1 2026 after selling out during the quarter.
  • LPL Financial sold 32,705 Regenxbio shares in Q1 2026, an estimated $471K.
  • LPL Financial first reported a position in Regenxbio in Q1 2019 and held it in 7 quarters.
  • LPL Financial's Regenxbio position peaked at $471K in Q4 2025.
  • 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.